InvestorsHub Logo
Followers 163
Posts 12871
Boards Moderated 1
Alias Born 01/26/2016

Re: Pyrrhonian post# 65888

Friday, 07/01/2016 10:50:59 AM

Friday, July 01, 2016 10:50:59 AM

Post# of 699187
Pyrrhonian,

We are closer than you think. If you understood the value of CXCR4 and a few other key receptor sites and their ligands you would know this. You led me to do extensive research in this area when you were posting about another company with a product in trials that helped repair and prevent additional heart muscle damage in ischemic areas after a heart attack. Once I realized how CXCR4 levels are regulated by certain gene sensitivity to oxygen levels things started to make more sense. CXCR4 is found on a wide variety of cells including certain very important subsets of cells. Some of the cells are able to act and react in such a way as to modify cellular behavior and or characteristics. The new scientific advisory board will, I'm sure, be sorting through a great deal of information fairly soon about the best next steps for implementation of existing technology but also, to some extent at least by a few, the direction of future research.

In my opinion many of the big biopharmas still have a great deal of pain in front of them but the offset for some of them is that many of the promising small bios can now be bought cheap during the great rebalancing that started a while back in anticipation of upcoming events.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News